HomeSOFW • TLV
add
Sofwave Medical Ltd
Previous close
ILA 2,772.00
Day range
ILA 2,767.00 - ILA 2,980.00
Year range
ILA 1,300.00 - ILA 3,209.00
Market cap
981.23M ILS
Avg Volume
60.90K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 20.99M | 43.35% |
Operating expense | 13.68M | 10.63% |
Net income | 1.52M | 199.15% |
Net profit margin | 7.23 | 169.19% |
Earnings per share | — | — |
EBITDA | 2.58M | 415.56% |
Effective tax rate | 8.17% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 24.35M | 15.50% |
Total assets | 44.88M | 12.23% |
Total liabilities | 18.32M | 22.66% |
Total equity | 26.55M | — |
Shares outstanding | 35.29M | — |
Price to book | 36.96 | — |
Return on assets | 12.53% | — |
Return on capital | 20.27% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 1.52M | 199.15% |
Cash from operations | 3.64M | 318.83% |
Cash from investing | -66.00K | -208.20% |
Cash from financing | -159.00K | 59.85% |
Net change in cash | 3.62M | 278.30% |
Free cash flow | 3.88M | 547.88% |
About
Sofwave Medical is an Israeli aesthetic medicine company with headquarters in California, United States. It is publicly traded, listed on the Tel Aviv Stock Exchange. Sofwave develops an ultrasound system for non-invasive dermatological aesthetic treatment to improve facial lines and wrinkles
and for short term improvement in the appearance of cellulite. Wikipedia
Founded
2015
Website
Employees
126